MDXG
MiMedx Group, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -14.3% ·
share flow -9.8% ·
net new positions -16.7%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 90 | 0 | 52.35M | $201.57M | +8 | −8 |
| Q1 2026 | 93 | 0 | 53.34M | $210.99M | +4 | −4 |
| Q4 2025 | 93 | +1 | 51.21M | $346.71M | +1 | — |
| Q3 2025 | 19 | 0 | 33.28M | $232.30M | — | — |
| Q2 2025 | 16 | 0 | 31.16M | $190.41M | +1 | −1 |
| Q1 2025 | 13 | -1 | 11.80M | $89.67M | — | −1 |
| Q4 2024 | 14 | +1 | 11.42M | $109.89M | +1 | — |
| Q3 2024 | 12 | -2 | 7.09M | $41.90M | — | −2 |
| Q2 2024 | 14 | — | 7.86M | $54.46M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 2.79M | +1.6% | $16.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 2.79M | +1.6% | $16.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 1.52M | -3.0% | $9.01M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Millennium Management ✦ | 576.92K | -35.1% | $3.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 488.13K | -23.7% | $2.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 445.97K | +1006.0% | $2.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Marshall Wace ✦ | 348.53K | +16.6% | $2.06M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Marshall Wace ✦ | 348.53K | +16.6% | $2.06M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 317.27K | +11.8% | $1.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 317.27K | +11.8% | $1.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Fisher Asset Management ✦ | 291.98K | -7.5% | $1.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 129.75K | +218.0% | $766,828 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Norges Bank ✦ (passive) | 70.40K | 0.0% | $416,064 | 0.0% | Held | 2 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 62.05K | -93.1% | $366,704 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 39.26K | +4.0% | $233,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| AQR Capital Management | $71,829 | was 0.0% |
| Point72 Asset Management | $40,194 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 234 holders, 112.82M shares, $439.18M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.